Tag: Navigating the Cancer Maze

Why Immunotherapy Month has been a Symbol of Hope for Cancer Patients | Grace Gawler

This week on Navigating the Cancer Maze I re-presented an interview with Dr Horst Lindhofer PhD, Munich, Germany who was the creator of Tri-Functional antibodies. In the last segment – I provide an overview and more resources plus coming events for those who live in or near Brisbane.

This week on Navigating the Cancer Maze I re-presented an interview with Dr Horst Lindhofer PhD, Munich, Germany who was the creator of Tri-Functional immune systemantibodies. In the last segment – I provide an overview and more resources plus coming events for those who live in or near Brisbane. For more information visit:

 http://www.qimrberghofer.edu.au       Interview links:

  www.trionresearch.de           OR    www.neoviibiotech.com/contact.html

Immunotherapy is not new. It is interesting to take a look at the  History of Immunotherapy and it’s  pioneers.

In the 1850s, doctors in Germany noticed that patients’ tumours would occasionally shrink if their tumour became infected. This observation led to the idea that the body’s immune system could be harnessed and made to fight cancer.

Around the same time, doctors throughout Europe, encouraged by the success of Edward Jenner’s smallpox vaccine, attempted to make a ‘cancer vaccine’ by injecting patients with crude extracts of tumours from other cancer patients. These treatments were largely ineffective, but the field of ‘immunotherapy’ was born.

Initial progress on immunotherapy was slow, and over a hundred years’ work in the laboratory yielded little success in actual cancer treatment. This all changed when in 1975, Georges Köhler and César Milstein, working in Cambridge, discovered how to make synthetic antibodies.

Their discovery, coupled with an ever-increasing understanding of the immune system, has led to a variety of treatments and strategies that use the immune system to tackle cancer. Some, such as the antibody-based breast cancer drug Herceptin, are now used routinely to treat cancer patients.

Professor Jérôme Galon, Ph.D. whom I recently interviewed on Navigating the Cancer Maze received the William B. Coley Award in 2010. The award was established in 1975 in honor of Dr. William B. Coley, a pioneer of cancer immunotherapy, whose daughter, Helen Coley Nauts, founded Cancer Research Institute. To understand  Immunotherapy – please take 7 minutes to view this excellent video:

Immunotherapy: Boosting the immune system to fight cancer

[youtube https://www.youtube.com/watch?v=-NNjDjXSJt0]

William B. Coley, in 1891, injected streptococcal organisms into a patient with inoperable cancer. He thought that the infection he produced would have the side effect of shrinking the malignant tumor. He was successful, and this was one of the first examples of immunotherapy. Over the next forty years, as head of the Bone Tumor Service at Memorial Hospital in New York, Coley injected more than 1000 cancer patients with bacteria or bacterial products. These products became known as Coley’s Toxins. He and other doctors who used them reported excellent results, especially in bone and soft-tissue sarcomas.

Despite his reported good results, Coley’s Toxins came under a great deal of criticism because many doctors did not believe his results. This criticism, along with the development of radiation therapy and chemotherapy, caused Coley’s Toxins to gradually disappear from use. However, the modern science of immunology has shown that Coley’s principles were correct and that some cancers are sensitive to an enhanced immune system. Because research is very active in this field, William B. Coley, a bone sarcoma surgeon, deserves the title “Father of Immunotherapy.”

Further acceptance of his ideas was brought about by Coley’s own children. His son Bradley (1892-1961), also an orthopaedic surgeon, succeeded him as the head of the Bone Tumor Service at Memorial Hospital. Bradley Coley’s major textbook on bone tumors was published in 1948, and while advocating surgery as the main treatment for bone sarcomas, he supported the use of Coley’s toxin as adjunctive therapy. He believed that it would be of value in preventing micro-metastasis. His daughter, Helen Coley Nauts (1907-2001), became a cancer researcher and devoted her life to the study of her father’s toxins. She tabulated every patient he treated and reviewed all his notes. She published 18 monographs and tabulated over 1000 of his cases and noticed that in 500 of these there was near-complete regression. She founded Cancer Research Institute in New York. 

Read stories of patients successes immunotherapy trials from Cancer Research Institute at: Select from the menu ‘Who is the Immunocommunity’ and select the drop down menu ‘Patients Stories’

http://www.theanswertocancer.org/

Immunotherapy can be local or systemic.

Local immunotherapy delivers the treatment to the affected area. For example, the BCG vaccine can be injected into the bladder to treat bladder cancer, as it causes inflammation that can cause the tumour to shrink.

Systemic therapy treats the whole body and is useful for targeting cancer that may have spread. In the 1980s, scientists at the Cancer Research UK Medical Oncology Unit at the Christie Hospital in Manchester showed that the protein interferon alpha could cause tumours to shrink in patients with low-grade lymphoma. Interferon is now used to treat several different types of cancer.

Immunotherapy can also be non-specific or targeted.

Non-specific immunotherapy works by boosting the body’s immune system in general, so that its natural cancer-killing activity is enhanced. Both of the examples of local and systemic therapies (above) are also examples of non-specific immunotherapy.

Targeted immunotherapy is designed to make the immune system specifically kill cancer cells. The following types of targeted immunotherapy are available or are in development:

Antibody-based therapies

Antibodies are proteins produced by the immune system. A type of white blood cell called a B-cell produces them in response to an infection. Normally, antibodies stick to foreign objects in the body and label them for destruction. Researchers have been trying to make antibodies that will attach themselves only to cancer cells. This can be useful in four ways.

  • It can stop the cancer from growing by stopping other essential ‘growth factors’ from sticking to it.
  • It can ‘tag’ the cancer for destruction by the immune system.
  • If cancer drugs or radioactive particles are attached to the antibody, it can deliver them directly to the cancer cell without harming the rest of your body.
  • An enzyme (a type of protein that can promote chemical reactions) can be attached to an antibody, and then given to a patient along with a chemical that can be turned into a powerful drug by the enzyme. This directs the drug to the cancer, and minimise side effects. This process is known as Antibody-directed Enzyme/Pro-drug Therapy (ADEPT).

Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1888599/

http://www.cancerresearchuk.org/

http://www.cancerresearch.org

http://www.qimrberghofer.edu.au/

FOR MORE INFORMATION ABOUT IMMUNO-THERAPY already available in Germany for Clinical use – please contact me via the contact form on this blog or email to my new email address for enquiries: germancancertreatments@gmail.com

 

How our immune System Fights Cancer|Knowledge to Help you Navigate the Cancer Maze Grace Gawler & Prof Jerome Galon

Do want to get some insights into the intricate working of your immune system? Navigating the Cancer Maze, Grace Gawler interviews Prof. Dr. Jerome Galon: Research Director at INSERM (National Institute of Health and Medical Research) & leader of the INSERM Integrative Cancer Immunology laboratory, at the Cordeliers Research Centre, Paris, France.

Do want to get some insights into the intricate working of your immune system and cancer? On Navigating the Cancer Maze, internet radio Grace Gawler interviews Prof. Dr. Jerome Galon: Research Director at INSERM (National Institute of Health and Medical Research) & leader of the INSERM Integrative Cancer Immunology laboratory, at the Cordeliers Research Centre, Paris, France.

PROF DR. JEROME GALON
PROF DR. JEROME GALON

Listen to the show by selecting the following link:

http://www.voiceamerica.com/episode/78656/how-our-immune-system-fights-cancer-knowledge-to-help-you-navigate-the-cancer-maze

 

Professor Galon’s current interests & major contributions concern basic & translational research in cancer immunology, using systems biology.

His laboratory has made some ground-breaking findings demonstrating that the adaptive immune response within a tumor was a better predictor of survival than traditional staging based on the size and spread of a tumor.The new wave of immunotherapies reflects what has been known for some time; that the answer to cancer is in you! But it is not that simple. Our immune system is complex and intricate & as science unravels its mysteries, we are developing new understandings of how the immune system can be captured & recruited in the laboratory; retrained and returned to you the patient!

Awards: In 2008 Prof Dr Galon was awarded The Colon Cancer Research Schaeverbeke Award, Fondation de France,& the Clinical Research Award, Rose Lamarca, Fondation pour la Recherche Médicale.

INSERM UMRS1138 Laboratory of Integrative Cancer Immunology (Team 15) Cordeliers Research Center 15 Rue de l'Ecole de Medecine 75006 Paris, France
INSERM
Laboratory of Prof Jerome Galon Integrative Cancer Immunology (Team 15)
Cordeliers Research Center

In 2010 he received the William B. Coley Award from the Cancer Research Institute, NY, USA, 2011: the French National Academy of Science & the French National Academy of Medicine (2011) awards.

He has published many scientific papers and book chapters.


Health professionals and interested patients;

Visit INSERM UMRS 1138
Cordeliers Research Center
 at http://www.ici.upmc.fr/

For more about Integrative Cancer Immunology Laboratory and their research projects, Immunoscore, publications, seminars and links.

Health professionals – I especially recommend the Publications page and homepage side bar at INSERM’s website.

Prof Galon was a guest of QIMR Berghofer Medical Research Institute, Brisbane Qld , Australia. See their website at http://www.qimrberghofer.edu.au/

To listen to the audio – live streaming log on to the URL below. You can download this and other interviews with cancer experts at:

http://www.voiceamerica.com/episode/78656/how-our-immune-system-fights-cancer-knowledge-to-help-you-navigate-the-cancer-maze

To be continued……..

Enjoy the weekend….Grace

How Your Body Can Fight Cancer – Immunotherapies are on their way Grace Gawler with Professor Rajiv Khanna

How Your Body Can Fight Cancer – Immunotherapies are on their way! QIMR Brisbane is celebrating their cancer research findings by hosting a series of immunology presentations during Immunotherapy Week, June 15 – June 21 2014. Special Guest speaker will be Professor Jérôme Galon, Cordelier Research Center, Paris, France whose topic is “Cancer cure may be inside you and unleashed by immunotherapy”. To bring public awareness to Immunotherapy Week at the QIMR Berghofer Medical Research Institute, Brisbane Professor Rajiv Khanna Director of immunotherapy and vaccine development was interviewed on Navigating the Cancer Maze radio this week to publicize the need to bring research findings and medical trials into public awareness.

How Your Body Can Fight Cancer – Immunotherapies are on their way!

QIMR Brisbane is celebrating their cancer research findings by hosting a series of immunology presentations during Immunotherapy Week, June 15 – June 21 2014. Special Guest speaker will be Professor Jérôme Galon, Cordelier Research Center, Paris, France whose topic is “Cancer cure may be inside you and unleashed by immunotherapy”.

907477-rajiv-khannaTo bring public awareness to Immunotherapy Week at the QIMR Berghofer Medical Research Institute, Brisbane Professor Rajiv Khanna Director of immunotherapy and vaccine development was interviewed on Navigating the Cancer Maze radio this week to publicize the need to bring research findings and medical trials into public awareness. In particular he discusses his breakthrough immunotherapy research on Glioblastoma Multiforme.

As well on Navigating the Cancer Maze, Prof Khanna also discusses his research and clinical trial results on nasopharyngeal carcinoma, an aggressive throat cancer that has has shown response to immune therapies.

Image: Above – Cancer researcher Professor Rajiv Khanna, pictured with patient Eddie Chen, has developed a promising new treatment. Picture: Annette Dew Source: The Courier-Mail.

CLICK HERE to read Janelle Miles Courier Mail article – ‘Queensland Institute of Medical Research scientist Rajiv Khanna unveils promising new treatment for aggressive throat cancer’  published FEBRUARY 02, 2012

To listen to this very interesting and highly informative audio interview or to download on itunes (both free of charge), visit the link below direct to voice America and my show webpage.

http://www.voiceamerica.com/episode/78495/navigating-the-brain-cancer-maze-promising-results-from-world-first-brain-cancer-trials

Grace Gawler NAVIGATING THE CANCER MAZE eCard

Promising Results from World-First Brain Cancer Trials Professor Rajiv Khanna | Grace Gawler on Navigating The Cancer Maze

It is imperative that breakthroughs in cancer treatments are known to the world. Worldwide, there are an estimated 240,000 cases of brain and nervous system tumors diagnosed each year; GBM is the most common, and the most lethal of these tumors. People speak of the War on Cancer, but it is our bodies that are at war with cancer cells via our immune system and its responses. Utilizing the immune system principle, scientists at the QIMR Berghofer Medical Research Institute, Australia, have used immunotherapy to create a major breakthrough in the treatment of the brain cancer known as Glioblastoma Multiforme (GBM).

Free informational cancer seminars Brisbane June 15 – 21 2014 Brisbane.

Click the link below to see other events presented by QIMR – for immunology week June 15 – 21 2014 Brisbane.

How your body can fight cancer Seminars

cancer-lambert_2469736bPromising Results from World-First Brain Cancer Trials Professor Rajiv Khanna Joins Grace Gawler on Navigating The Cancer Maze To Talk about a Brain Cancer breakthrough.

Phoenix, AZ — 06/13/2014 — Voice America Talk Radio Network, Internet broadcasting pioneer, producing and syndicating online audio and video, today announced that Professor Rajiv Khanna QIMR Berghofer Medical Research Institute Australia will join Grace Gawler host of Navigating the Cancer Maze program on the VoiceAmerica Health and Wellness Channel (http://www.voiceamerica.com/show/2125/navigating-the-cancer-maze) Friday, June 13, 2014 at 12 noon Pacific Time.

NOTE: show goes live to air 5 am Brisbane Australia time Saturday 14 June 2014. Available streaming audio any time after 9 am this Saturday and available to download on itunes indefinitely.

It is imperative that breakthroughs in cancer treatments are known to the world. Worldwide, there are an estimated 240,000 cases of brain and nervous system tumors diagnosed each year; GBM is the most common, and the most lethal of these tumors. People speak of the War on Cancer, but it is our bodies that are at war with cancer cells via our immune system and its responses.  Utilizing the immune system principle, scientists at the QIMR Berghofer Medical Research Institute, Australia, have used immunotherapy to create a major breakthrough in the treatment of the brain cancer known as Glioblastoma Multiforme (GBM). Study leader, Professor Rajiv Khanna, said most of the study participants lived much longer than the six-month prognosis normally given to a patient with recurrent GBM, and some patients showed no signs of disease progression. “It is early days, but this is exciting,” Professor Khanna said.

“Survival rates for this aggressive cancer have barely changed in decades. There is an urgent clinical need for new treatments. “If this treatment can buy patients more time, then that is a big step forward.”

GBM
Image of Brain GBM

GBM is the most common malignant brain cancer, diagnosed in about 800 Australians every year.  Despite surgery, radiotherapy and chemotherapy, less than 10% of patients survive beyond five years. This study built on previous research which found that many brain tumours carry cytomegalovirus (CMV). About half of all Australians have the virus, but usually show no symptoms.

Professor Khanna developed a technique to modify the patients’ T-cells in the laboratory, effectively “train” them to attack the virus, and then return them to the patient’s body.  When the killer T-cells destroyed the virus, they also destroyed the cancer. “It’s becoming increasingly clear that immunotherapy – manipulating a person’s own immune system – is a rich new frontier for cancer treatment,” Professor Khanna said.

The QIMR is celebrating their research findings by hosting a series of immunology and cancer presentations between June 15 and June 21 in Brisbane. For those people who cannot attend, watch out on the websites for more information. www.qimrberghofer.edu.au   or  www.gracegawlermedia.com

The Phase I trials were conducted at Brisbane’s Wesley Hospital, under the leadership of neurosurgeon Professor David Walker.  “Working with patients with malignant brain tumors can be distressing, because we know so many will succumb,” Professor Walker said. “But this new branch of therapy lets us offer some hope that the future is going to be brighter, that new and innovative treatments mean things will hopefully improve in the future. “We have a long way to go, and there is hard work to be done, but we seem to be on the right track, and it is a pleasure to work with scientists at QIMR Berghofer to try to make a real difference.”

The research team is now keen to begin the next phase of trials, involving patients at an earlier stage of the cancer’s development. “These would be patients who have just been diagnosed and are about to start the standard treatments – surgery, then radiotherapy or chemotherapy.  We would generate the T cell therapy before their standard treatment, and then administer T cells in conjunction with the standard therapy,” Professor Khanna said.

“We hope that the treatment can be even more effective if given at an earlier stage of the disease.”

This study is published online in the prestigious US journal Cancer Research and can be viewed at http://cancerres.aacrjournals.org/content/early/recent

The research was funded by Flagship Funding from the Rio Tinto Ride to Conquer Cancer, the NHMRC and private donors.

The QIMR Berghofer Medical Research Institute is a world leading translational research institute focused on cancer, infectious diseases, mental health and a range of complex diseases. Working in close collaboration with clinicians and other research institutes, our aim is to improve health by developing new diagnostics, better treatments and prevention strategies.

For more information about QIMR Berghofer Visit: www.qimrberghofer.edu.au

Navigating the Cancer Maze | i am the answer to cancer |Cancer Immunotherapy Month

Navigating the Cancer Maze | i am the answer to cancer |Cancer Immunotherapy Month. Where is the answer to cancer? According to Jill O’Donnell-Tormey, Ph.D and the organization she represents,Cancer Research Institute (CRI); the answer is ‘i am the answer to cancer’; yes-the patients immune system holds the answer to cancer!

Navigating the Cancer Maze | i am the answer to cancer |Cancer Immunotherapy Month
June 6, 2014
Did you know that June is Cancer Immunotherapy Month? Tune in to Navigating the Cancer Maze for inspiring listening and learn about the good news – the Answer to Cancer
Dr. Jill O'Donnell-Tormey PhD CEO Cancer Research Institute NY
Dr. Jill O’Donnell-Tormey PhD CEO Cancer Research Institute NY

Where is the answer to cancer? According to my guest Jill O’Donnell-Tormey, Ph.D and the organization she represents,Cancer Research Institute (CRI); the answer is ‘i am the answer to cancer’; yes-the patients immune system holds the answer to cancer! Select link below to listen to audio

http://www.voiceamerica.com/episode/78363/navigating-the-cancer-maze-i-am-the-answer-to-cancer-cancer-immunotherapy-month

The CRI is a non-profit organization founded in 1953 & today’s global leader in supporting & coordinating research aimed at harnessing the immune system’s power to conquer all cancers. Jill will explain immunotherapy & its value to cancer patients as well as the different types of cancer immunotherapy available. There will be patient stories & an exploration of the very latest in immunotherapy. A New Cancer Immunotherapy Website for Patients and Caregivers was launched recently. Get on board with supporters like Olivia Newton John who recently lent public support to CRI.   http://www.cancerresearch.org         http://www.TheAnswerToCancer.org

Listen to Navigating the Cancer Maze 12 Noon Fridays – live from Arizona (PST) – Saturday Australia 5am free to air or download and listen later – available free download on itunes.

READ MORE:

http://www.sbwire.com/press-releases/dr-jill-odonnell-tormey-phd-ceo-director-of-scientific-affairs-of-the-cancer-research-institute-ny-joins-grace-gawler-on-navigating-the-cancer-maze-to-talk-about-cancer-immunotherapy-month-516331.htm

LISTEN TO INTERVIEW:

http://www.voiceamerica.com/episode/78363/navigating-the-cancer-maze-i-am-the-answer-to-cancer-cancer-immunotherapy-month

Please remember to Like us facebook & spread the good news about the Answer to Cancer!

CIM-homepage-slider_Cancer-Immunotherapy-Month_960x395-JUNE

The Dangers of Meditation. Advice for Meditators. An interview with Leigh Brasington by Willoughby Britton.

Meditation can open a can of worms in our psychology. This is a surprise to many people. I have often asked my self the same question that is explored in the first paragraph of this blog. For people who are dealing with illness, such as cancer; care must be taken whilst developing a practice that will assist and not detract from their recovery. Many people around the Globe are turning toward Buddhist practices of meditation. This excellent blog brings to light something that is little discussed in meditation circles – the dangers and issues that can be associated with meditation.

Meditation can open a can of worms in our psychology. This is a surprise to many people. I have often asked my self the same mindfulnessquestion that is explored in the first paragraph of this blog (see below).

For people who are dealing with illness, such as cancer; care must be taken whilst developing a practice that will assist and not detract from their recovery.

Many people around the Globe are turning toward Buddhist practices of meditation.

This excellent blog brings to light something that is little discussed in meditation circles – the dangers and issues that can be associated with meditation. I also suggest that you read http://youreternalself.com/meditation.htm

Grace Gawler interviews Dr Bruce Whelan |How to Navigate the Cancer Maze with the Help of your General Practitioner

Grace Gawler Interviews Dr Bruce Whelan a specialist GP who has been in Practice for 45 years. A previous guest on the show, episode titled ‘Spinning Gold from Straw: How trauma transformed a Doctor’s Life and Practice’; today I will be asking him about his role as a GP. ersonal involvement with the Bali bombings in 2002 made an impact of his life & practice leading to his interest in psychiatry. His special areas of interest are general psychiatry, drug addiction medicine, pain management & issues related to cancer medicine.

Navigating the Cancer Maze – with Grace Gawler:

How to Navigate the Cancer Maze with the Help of your General Practitioner—Cancer Practice & Emotional Medical Apple shutterstock_70520200Support

Listen to the Show-Free to download for listening later or listen online:

http://www.voiceamerica.com/episode/77930/how-to-navigate-the-cancer-maze-with-the-help-of-your-general-practitioner-cancer-practice-and

Dr Bruce Whelan is a specialist GP who has been in Practice for 45 years. A previous guest on the show, episode titled ‘Spinning Gold from Straw: How trauma transformed a Doctor’s Life and Practice’; today I will be asking him about his role as a GP. The role of the GP is ever-changing; once the family doctor who made house calls and knew the names of all of a patient’s family members, the role of the GP has morphed into rapid delivery medicine with time constraints. However, there is a new and emerging role for GP’s in cancer and supportive Care medicine. The need is great for patients and families and a new model of care is timely. A graduate of the University of Queensland School of Medicine-1967, Dr Bruce Whelan has been in general practice since 1971.

He also specializes in pain management, so I will be specifically asking him about pain management in cancer medicine.

 

BIO DR Bruce Whelan – Specialist GP

 Dr Bruce Whelan has been in general practice since 1971. Dr Bruce Whelan specialist GPHe has worked in challenging rural Australia practice environments including indigenous health.

With 45 years experience, his ethic is treating the whole person using the best of modern psychology & general psychiatry in combination with the best of modern medicine. Personal involvement with the Bali bombings in 2002 made an impact of his life & practice leading to his interest in psychiatry. His special areas of interest are general psychiatry, drug addiction medicine, pain management & issues related to cancer medicine.

He has been involved with teaching medical students at Bond & Griffith Medical Schools Gold Coast Australia. He has a deeply inquiring mind, sharp differential diagnosis skills, & his experience as a GP who understands his patients’ grief and trauma is invaluable. He lives on a yacht, loves fishing, oil painting, classical music & life!

http://www.voiceamerica.com/episode/77930/how-to-navigate-the-cancer-maze-with-the-help-of-your-general-practitioner-cancer-practice-and

 

Navigating the Cancer Maze with Grace Gawler: Part 2 Why We Need to Search for the Truth in Cancer Cure Stories

This week in part one of my Radio Show Navigating the Cancer Maze On Voice America, we are exploring some good news research. This is an information–packed episode with resources to treatments and research aimed at cancer patients being informed of the latest treatments.Today I share some interesting cancer research – not anecdotes – but solid science that is leading the way with realistic hope for cancer patients. Some treatments are already in Clinical practice. I also shed some good news on Chemotherapy and news ways of delivering it to cancer.

This week in part one of my Radio Show Navigating the Cancer Maze On Voice America, we are exploring some good news research. This is an information–packed episode with resources to treatments and research aimed at cancer patients being informed of the latest treatments.
Last week on the show I interviewed ethicist Dr Julie Crews where we discussed lack of science, poor research, lask of evidence and the problems with anecdotal Stories. If you missed the interview you can download it. Click here

DNA repair
DNA repair

Today I share some interesting cancer research – not anecdotes – but solid science that is leading the way with realistic hope for cancer patients. Some treatments are already in Clinical practice. I also shed some good news on Chemotherapy and news ways of delivering it to cancer.  Click here to listen now

Now to some snapshots and resources from the show:
Researchers and clinicians have focused on ways to minimize side effects without compromising ‘kill capacity’ of drugs. Another focus has been to find different ways to deliver chemotherapy making it effective and less toxic.

 German interventional radiologist Professor Thomas Vogl, has published more than 100 papers. Author & co author of many medical textbooks, he uses a wide variety of innovative cancer treatments including TACE & TACP. Via the femoral artery, he finds his way through networks of blood vessels with fine catheters to delivers a payload of chemotherapy directly into tumours or body cavities where difficult to treat tumours exist. The side effects are minimal to none. Having personally watched dozens of procedures; the Professor is a master of his craft. He is one of the few, successfully treating Mesothelioma (asbestosis), significantly extending lives. http://www.germancancertreatments.com/drs-treatments/

A Recent Australian discovery in medicine EDV technology had a heart-warming beginning. Having made a solemn promise to a dying colleague, two scientists devoted their lives to finding a new way to treat cancer and in the past decade have made a lot of progress. The website is must see for all Australians in particular. The new technology is explained. I suggest you navigate the menus and in particular view the videos to get an understanding of this amazing and ingenious technology. www.engeneic.com

Dr Himanshu Brahmbhatt and Dr Jennifer MacDiarmid
Dr Himanshu Brahmbhatt and Dr Jennifer MacDiarmid

The couple responsible for EDV technology Dr Himanshu Brahmbhatt and Dr Jennifer MacDiarmid were featured on ABC Australian story some time ago. Also a must watch for anyone interested in targeted cancer treatment:
http://www.abc.net.au/austory/specials/holygrail/default.htm

*From a funding viewpoint – this Group – EnGeneIC is worthwhile of your philanthropic input*.

Chemotherapy often gets bad press. Some tolerate it better than others. Have you ever wondered why some patients who have chemotherapy and never change their diet or lifestyle or taken supplements – get through cancer and have long remissions – sometimes for their entire life time? Having worked with cancer patients for 40 years, I have seen thousands of them!
A group of Italian researchers recently published a paper that may shed some light on why people respond differently to chemotherapy – is it dependent upon the robustness of their immune system? They are also suggesting that we should not throw the baby out with the bath water in terms of chemotherapy use. They say it is now becoming evident that standard chemotherapy agents can deeply have an impact on both tumour and host immune system.

Conventional anticancer chemotherapy has been historically thought to act through direct killing of tumour cells. This concept stems from the fact that cytotoxic drugs interfere with DNA synthesis and replication. However we now know that Chemotherapeutic agents stimulate both the innate and adaptive arms of the immune system. The ensemble of results discussed in their research paper contributes to pave the way towards mechanism-based, rather than empirical, rationales for combination of specific chemotherapeutic agents with selective immunotherapeutic interventions, opening novel horizons for more effective management of cancer patients.

Data obtained in both animal models and humans suggest that immunotherapy should immediately follow chemotherapy (1–2 days interval) to achieve the best synergism between the two treatments!
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer is published in:
Cell Death and Differentiation (2014) 21, 15–25; doi:10.1038/cdd.2013.67; published online 21 June 2013    http://www.nature.com/cdd/journal/v21/n1/abs/cdd201367a.html

This blog will be continued later today with part 3 & 4 with more information about new treatments for ovarian cancer,  dendritic cell vaccination and brain tumours plus…. some Prevention and risk reduction suggestions from a new book published by an oncology physician…… Informed weekend reading for all who are interested in How to Navigate the Cancer Maze. Until then…

Enjoy the weekend!
Grace

Professor Ian Frazer, The Man who Saved a Million Lives interview with Grace Gawler

During this past week, a book about Professor Frazer’s personal story and his discoveries relating to viruses and cancer was launched in Brisbane. It is one of those books that is a must read – an important contribution to Australia medical science history! Authored by Madonna King, the book titled: “IAN FRAZER….The Man who saved a Million Lives” is available in Australia from Dymocks, Target and many other bookstores. Buy online at UQP. Listen to my Interview with Prof Ian Frazer on Voice America…..

Have you ever wondered about the nature of viruses? What they are made of… how they operate….. and how they can do a takeover bid in our bodies and make us so ill?  Did you know that viruses are implicated as a causative factor in the development of many cancers – not only cervical cancer? The bigger question begs; what can we do when a virus strikes and can we prevent a virus from causing cancer?

Fortunately for all of us Prof Ian Frazer began asking these questions at an early age.  At about the age of nine, he remembers lining up with schoolmates for their polio vaccinations. He said in a recent Reader’s Digest issue: “The needle got my attention,” he says – which is where most kids are happy to leave it. “Then, I realized there were [crippled] kids around who had had polio. That got me interested in how the body fights infection … how the body repairs itself.” Thanks to his earlier scientific curiosity, HPV 16 – one of the leading causes of cancer of the cervix, is in process of being eradicated worldwide.
During this past week, a book about Professor Frazer’s personal story and his discoveries relating to viruses and cancer was launched in Brisbane. It is one of those books that is a must read – an important contribution to Australia medical science history!

Prof Ian Frazer
The Book that tells of story of one of the most important discoveries in recent medical science

 Authored by Madonna King, the book titled: “IAN FRAZER….The Man who saved a Million Lives” is available in Australia from Dymocks, Target and many other bookstores. If you haven’t bought your Father’s Day gift yet – this one would a fantastic idea. (A percentage of proceeds from the book will be donated to the Australian Cervical Cancer Foundation). Not available in e-book yet, the book is published by University of Queensland Press BUY ONLINE HERE
If you want to hear more about viruses and Professor Frazer’s work – Please do not miss listening to today’s special edition of Navigating the Cancer maze on Voice America’s Health and Wellness channel: http://www.voiceamerica.com/episode/72540/navigating-the-cancer-maze-with-professor-ian-frazer
About
Professor Ian Frazer AC, FRS, FAACEO, 2006 Australian of the Year & Director of Research at the Translational Research Institute, Brisbane Australia; is one Australia’s most celebrated medical research scientists. Prof Frazer has received numerous national and international awards for his work in developing the technology that has enabled vaccines to help prevent cervical cancer. To link a virus to cancer in the 1980’s was contentious, but Ian Frazer persevered, convinced this needed further investigation. Now his successful research and development of a cervical cancer vaccine has sold worldwide under the brand names Gardasil and Cervarix.  In May 2011, Prof Frazer was elected as a Fellow of the Royal Society of London. This achievement elevates him to the same status as world renowned scientists such as Stephen Hawking and Sir Isaac Newton. Today’s interview will probe in depth the connection between viruses and cancer and the function of immunity in viral destruction and management.
Short BIO – Professor Ian Frazer
Professor Frazer, a renal physician & clinical immunologist from Edinburgh, Scotland; came to Melbourne Australia in 1981 to pursue studies in viral immunology and autoimmunity at the Walter and Eliza Hall Institute of medical Research.
In 1985, he moved to Brisbane to assume a teaching post with the University of Queensland & was appointed Director of the Centre for Immunology and Cancer Research in 1991. He has taught immunology to undergraduate & graduate students at the University & has research interests in immune-regulation and immuno-therapeutic vaccines for HPV (Papilloma virus) associated cancers.

Translational Research Institute Brisbane Australia
Translational Research Institute Brisbane Australia

Now involved in revolutionary research, he is developing a vaccine/treatment for HSV-2 – the virus implicated in genital herpes.
He is a past President of the Cancer Council Australia, Chairman of the Australian Cancer Research Foundation’s Medical Research Advisory Committee & Chair of the International Agency for Research on Cancer Scientific Advisory Committee.

More on this topic and a review of the book IAN FRAZER….The Man who saved a Million Lives in my next blog at www.gracegawlermedia.com

Navigating the cancer Maze on Voice America Heath and Wellness Channel is presented each week by the Grace Gawler Institute in the interest of informing and educating the worldwide cancer community. www.gracegawlerinstitute.com

 Listen to the interview at :    http://www.voiceamerica.com/episode/72540/navigating-the-cancer-maze-with-professor-ian-frazer

Navigating the Cancer Maze Grace Gawler Voice America-Strath Tonic immune health, quality of life and wellbeing for cancer patients

Strath contains 61 vital substances, from which each body takes what it needs,” says David Pestalozzi. Thirty-five studies of varying influence have been carried out to date. See Research at www.bio-strath.ch

Part 2 Strath (Bio-Stath) Tonic

To read Part 1 published 10 August – scroll this page. Part 3 will be published 13 August:

Since 1964, the production plant for “Strath” has been based above Herrliberg. A staff of six looks after the manufacturing process today. The company’s product range includes herbal remedies . The key section of the plant, some of which is underground, is the fermentation chamber with its four chromium-plated steel vats, each holding 12,000 litres. The food supplement makes use of the ability of yeast cells to “digest” the extracts of some 50 herbs added to them and to make the essence of these herbs accessible to the human body. http://www.voiceamerica.com/episode/72190/swiss-herbal-tonic-strath-successfully-impacts-wellbeing-and-quality-of-life-in-cancer-patients

Strath is produced here at Herrliberg near ZurichBut the herbal yeast cells obtained in this way still have to undergo a fermentation process that causes them to “burst” and liquefy. The production process lasts for two months and all that is added at the end is malt extract, honey and a little orange juice.
The end product is totally stable and can be stored for five years, even after the bottle has been opened: Strath contains 61 vital substances, from which each body takes what it needs,” says David Pestalozzi. Thirty-five studies of varying influence have been carried out to date. See Research at www.bio-strath.ch Continue reading “Navigating the Cancer Maze Grace Gawler Voice America-Strath Tonic immune health, quality of life and wellbeing for cancer patients”

error: Content is protected !!